UUID: CBSSDBSC- TDCD- 474B— SACS- BBISDBBRA1eC31c
TCGA- BG- ABOT- 91A- -PR

I|| ||||IIIIIIIIIIIIIIIIIIIIIII III||II|III|I||||||IIIIIIIIIIIIIIaIICIIEd
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII||I|II|II|II
I IIIIIIIIIIIIIIIIIIII||||||||I IIIIIII II III II I IIII I II III||I|I I III

Accession: ”

Specimen Date/Time :

******* MODIFIED REPORT - REVIEW ADDENDUM SECTION ****’;*'*
DIAGNOSIS '

(A) PLEURAL IMPLANT: F
THYMOMA IN CONNECTIVE TISSUE (4.0 CM).
(B) DIAPHRAGMATIC-PLEURAL IMPLANTS:
THYMOMA IN CONNECTIVE TISSUE (LARGEST NODULE 7.0 CM).
(C) LEFT LOWER LOBE WEDGE RESECTIONI D .x ,3) ‘
Lung parenchyma no tumor present. . (up? 1C L j
([3) AORTIC PLEURA: 3
' Fibroconnective tissue with focal lymphoid follicle no tumor present “Rik-’7 ”L4“ 140* IﬂLﬂ1I‘Sb?
(E), RIGHT DIAPHRAGMATIC PLEURA; Hg 3 5ERIC
F ibroconnective tissue with focal lymphoid follicle, no tumor present. (1):» 0 f"
(F) ESOPHAGEAL PLEURA; ”(A a???
Fibroconnective tissue with focal lymphoid follicle, no tumor present. {jktiﬂun LA” N as B 55:13) 5
(G) COSTO~PHRENIC ANGLE K/jI, (7. <
THYMOMA IN CONNECTIVE TISSUE (0 8 CM) L. 03L; .55 7 ’57
(H) CARDIAC PLEURA: Wt: to 7’ M
THYMOMA IN CONNECTIVE TISSUE (LARGEST MODULE 0 6 CM). [4% ,
0) ADDITIONAL CARDiAC PLEURA2' Iaollwdlquzot‘} (’0 ‘3“ 5
(J) ETHEIEMOMA IN CONNECTIVE TISSUE (LARGEST NODULE 2.7 CM). 97‘) 63/5/ILI

For gross examination only.

Entire report and diagnosis completed by

GROSS DESCRIPTION

’

(A) PLEURAL IMPLANT- A tan- red membranous tissue fragment (8 O x 3. 0 x 1 5 cm). In the midportion of the specimen there Is
a tan ﬁrm nodular mass (4.0 x 1.? x1 5 cm)

INK CODE: Blue— edges of specimen
SECTION CODE: Representative sections submitted from tumor to peripheral specimen edge. A1-A7.
(B) DIAPHRAGMATICIPLEURAL iMPLANTS- .A tan-red membranous tissue fragment (24.0 x 13.0 x 2. 7 cm). The specimen

contains multiple nodules ranging from 0 3 to 7 0 cm in greatest dimension Cut sections of these nodules reveal a tan firm
partially necrotic surface.

Representative sections submitted ”1 81-87
(C) LEFT LOWER LOBE WEDGE RESECTION- A dark red wedge lung resection (4 0*): 3. O x 0.6 cm) containing a 4 0 cm long
stapie line Cut sections reveal unremarkable pulmonary parenchyma
INK CODE: Blue- adiacent to stapled parenchymal margin.
SECTION CODE: Ct parenohymal margin en face; C2—C4 entirely submitted specimen
(0) AORTIC PLEURA— A tan irregular membranous tissue fragment (5. 5 x 4 0 x 0.2 cm). Cut section is unremarkable.
SECTION CODE: Entire specimen submitted in [31:06.
(E) RIGHT DIAPHRAGMATIC PLEURA A tan-red membranous tissue fragment (2 5 x 2. 3 x D 3 cm) Cut section reveals a
ﬁbrous surface.
SECTION CODE: E1, entire specimen submitted an E1 —E3.

(F) ESOPHAGEAL PLEURA - A ten irregular membranous tissue fragment (3.0 x 1.7 x,0.3 cm). Cut section is unremarkable.
SECTlON CODE: Entire specimen submitted in F1 and F2.

Page: 2

M‘” —

Accession: 4,:

Sbecimen Date/Time:

,3

(G) COSTO—PHRENIC ANGLE - A tan irregular membranous tissue fragment (2.5 x 1.7 x 0.2 cm). A tan nodular firm mass (0.8 x
0.6 x 0.3 cm) is noted. _ .

SECTION CODE: Entire specimen submitted in 61-62.

(H) CARDIAC PLEURA - Multiple ten irregular tissue fragments (5.0 x 4.0 x 0.2 cm in aggregate). Cut Section reveals multiple
nodules ranging from 0.3 to 0.6 cm in greatest dimension.
Representative sections submitted in H4 and H2.

(l) ADDITIONAL CARDIAC PLEURA ~ Multiple tan irregular membranous tissue fragment (5.5 x 4.5 x 0.3 cm). The specimen
containsmultiple nodules ranging from 1.0 to 2.7 cm in greatest dimension.
SECTION CODE: Representative sections submitted in l1 and l2. "'

(J) 6TH RIB - Four tan-red rib segments (ranging from 1.0 x 1.0 x 0.9 cm to 5.5 x 1.6 x 0.5 cm). The specimen is submitted to the
bone tab for further processing. ‘

CLlNlCAL HISTORY

Mass, left lung.

SNOMED CODES
T-ZQOOO, hit-80506

"Some tests reported here may have been developed and performance characteristics determined by
speciﬁcally cieared or approved by the US. Food and Drug Administration."

These tests have not been '

Released by:

r

Start of ADDENDUM.

.BNTSdedaWW

Primary Tumor Sit: Discrepancy
HIPAA Discrepanw

 

Page: 3

Specimen Date/Time:

ADDENDUM

Addendum com-pieted by

DIAGNOSIS

(J) 6TH RIB:
Bone tissue submitted for decalcification is free of tumor.

Released by;

. ~—.-~~-END OF REPORT—«m,

til—rm -.
Accession: . . . .

 

 

TCGA Pathologic Diagnosis Discrepancy Form ”‘00

 

 

 

 

 

 

Wong; The TCGA Pathologic Diagnosis Discrepancy Form should be com pleted when the pathologic diagn osis.
documented on the initial'pathology repartfor a case submitted for TC GA is inconsi'Stent with the diagnosis provided on the
Case Quality Control Form completed far the submitted case.

 

 

 

 

 

 

 

 

Tissue Source Site (T88); T55 identifier: _ 4 TSS Unique Patient Identiﬁer:
Completed By (Interviewer Name on Completed Date:
[Diagnosis information _ g
# Data Element Entry Alternatives Working Instructions
, Provide the diagnosis] histologic subtype[s} documented on
Patholcigic Diagnosis Thymoma the initial pathology report forthis case; lithe histology for
1 Provided an Initial W this case is mixed, provide all listed subtypes.
Pathology Report
, . Provide the histologic features selected on the 'I‘CGA Case
Elsmmglc features 0f Bl Quality Control Form completed for this case.
2 the sample provxded
' for TCGA, as reﬂected
on the CQCF.

 

 

 

Discrepancy between. Pathology Reynrtand Case Quality Control Form

 

3 Provide the reason for Prozixile a reason (geocgbing why the diagnosis on the initial
the discrepancy pat o ogy report or t is case is not. consxstent With the
between the pathology H lStOiogIC subtype was not done diagnos 3 selected on the TCGA Case Quality Control Form
report and the TCGA at initial pathologic diagnosis.

Case Quality Control
Form.

Reviewing Pathologist has re—
reviewed the case slide and
provided the WHO subtype

 

Name of TSS Reviewing Provide the name ol‘the pathologist who reviewed this case
4 Pathologist or for TCGA.

Biorepository Director

 

 

 

 

 

! acknowledge that the above information provided by my Institution Is true and correct and has been quality controlled.-

 

TSS Reviewing Pathologist or Bioreposu'ory Director Date

I acknowledge ﬁmtgthe above information provided by my lnstiala‘on Is true and correct and. has been quality convened. TheAwending Pathologist or the
Department Chairman has been informed or is aware aftlie above discrepancy in diagnoses.

 

Principal investigator Signature Date

 

